Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). AptarGroup's share price for the quarter that ended in Mar. 2025 was $148.38. AptarGroup's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 66 Mil. Therefore, AptarGroup's market cap for the quarter that ended in Mar. 2025 was $9,808 Mil.
AptarGroup's quarterly market cap
declined
from Sep. 2024 ($10,653 Mil) to Dec. 2024 ($10,447 Mil) and
declined
from Dec. 2024 ($10,447 Mil) to Mar. 2025 ($9,808 Mil).
AptarGroup's annual market cap
increased
from Dec. 2022 ($7,171 Mil) to Dec. 2023 ($8,147 Mil) and
increased
from Dec. 2023 ($8,147 Mil) to Dec. 2024 ($10,447 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AptarGroup's Enterprise Value for Today is $11,570 Mil.
AptarGroup Market Cap Historical Data
The historical data trend for AptarGroup's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, AptarGroup's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AptarGroup's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's Market Cap distribution charts can be found below:
* The bar in red indicates where AptarGroup's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
AptarGroup's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AptarGroup (NYSE:ATR) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
AptarGroup Market Cap Related Terms
Thank you for viewing the detailed overview of AptarGroup's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ATR has been successfully added to your 